Chromosome 1p36 Deletion Syndrome
0.520
ChromosomalRearrangement
disease
ORPHANET
"Further delineation of novel 1p36 rearrangements by array-CGH analysis: narrowing the breakpoints and clarifying the ""extended"" phenotype."
22766398
2012
Chromosome 1p36 Deletion Syndrome
0.520
Biomarker
disease
MGD
Deletion of the mouse homolog of KCNAB2, a gene linked to monosomy 1p36, results in associative memory impairments and amygdala hyperexcitability.
21209188
2011
Chromosome 1p36 Deletion Syndrome
0.520
ChromosomalRearrangement
disease
ORPHANET
[Effect of carbamazepine on epilepsy with 1p36 deletion syndrome].
17633087
2007
Chromosome 1p36 Deletion Syndrome
0.520
Biomarker
disease
BEFREE
Although haploinsufficiency of the potassium channel beta-subunit (KCNAB2 ) is thought to be responsible for intractable seizures in the 1p36 deletion syndrome , this was not the case for 3 of the 11 patients in this study.
16023556
2005
Chromosome 1p36 Deletion Syndrome
0.520
Biomarker
disease
MGD
Genetic modifiers of the Kv beta2-null phenotype in mice.
15720404
2005
Chromosome 1p36 Deletion Syndrome
0.520
Biomarker
disease
MGD
Genetic analysis of the mammalian K+ channel beta subunit Kvbeta 2 (Kcnab2).
11825900
2002
Chromosome 1p36 Deletion Syndrome
0.520
Biomarker
disease
BEFREE
Hemizygosity of this gene in a majority of monosomy 1p36 syndrome patients with epilepsy suggests that haploinsufficiency for KCNAB2 is a significant risk factor for epilepsy.
11580756
2001
Epilepsy
0.310
Biomarker
disease
CTD_human
Nine patients are deleted for the KCNAB2 locus, and eight (89%) of these have epilepsy or epileptiform activity on EEG.
11580756
2001
Epilepsy
0.310
GeneticVariation
disease
BEFREE
Nine patients are deleted for the KCNAB2 locus, and eight (89%) of these have epilepsy or epileptiform activity on EEG.
11580756
2001
Epilepsy, Cryptogenic
0.300
Biomarker
disease
CTD_human
Loss of the potassium channel beta-subunit gene, KCNAB2, is associated with epilepsy in patients with 1p36 deletion syndrome.
11580756
2001
×
CUI:
C0236018
Disease:
Aura
Aura
0.300
Biomarker
phenotype
CTD_human
Loss of the potassium channel beta-subunit gene, KCNAB2, is associated with epilepsy in patients with 1p36 deletion syndrome.
11580756
2001
Awakening Epilepsy
0.300
Biomarker
disease
CTD_human
Loss of the potassium channel beta-subunit gene, KCNAB2, is associated with epilepsy in patients with 1p36 deletion syndrome.
11580756
2001
Seizures
0.110
GeneticVariation
phenotype
BEFREE
Because ion channels are important determinants of seizure susceptibility and the voltage-gated K(+) channel beta-subunit gene, KCNAB2 , has been localized to 1p36, we propose that deletion of this gene may be associated with the epilepsy phenotype.
11580756
2001
Seizures
0.110
Biomarker
phenotype
HPO
QT interval feature (observable entity)
0.100
GeneticVariation
phenotype
GWASCAT
Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization.
24952745
2014
Autistic Disorder
0.100
Biomarker
disease
HPO
Cardiomyopathy, Dilated
0.100
Biomarker
group
HPO
Constipation
0.100
Biomarker
phenotype
HPO
Cryptorchidism
0.100
Biomarker
disease
HPO
Deglutition Disorders
0.100
Biomarker
group
HPO
Patent ductus arteriosus
0.100
Biomarker
disease
HPO
Dwarfism
0.100
Biomarker
disease
HPO
Failure to Thrive
0.100
Biomarker
disease
HPO
Fatty Liver
0.100
Biomarker
disease
HPO
Gastroesophageal reflux disease
0.100
Biomarker
disease
HPO